Tag: Vaccines
Another Significant HIV Vaccine Trial Fails
A second HIV vaccine trial has been halted after it failed to lower the risk for infection among high-risk people
Vaccination Coverage Down in Kindergarteners During 2021 to 2022
Vaccination coverage decreased 0.4 to 0.9 percent compared with the 2020 to 2021 school year
Vaccine Coverage by Age 24 Months Unchanged During Pandemic
Coverage with combined seven vaccine series decreased for children living below federal poverty level, in rural areas
Overall Increase Seen in COVID-19 Vaccine Acceptance Globally
Vaccine hesitancy varied considerably; 12.1 percent of vaccinated individuals hesitant about booster doses
Waning Immunity Most Consistent With Recent Mumps Outbreaks
Estimated 32.8 percent of individuals lose vaccine-derived immunity by age 18 years in the United States
Free Spike Antigen ID’d in Post-SARS-CoV-2 mRNA Vaccine Myocarditis
However, mRNA vaccine-induced immune responses did not differ for those who developed myocarditis and those who did not
Racial/Ethnic Variation Seen in COVID-19 Vaccination Status in Children
Non-Hispanic Asian children and adolescents have the highest vaccination coverage, followed by Hispanic/Latino children
Increasing Staff Vaccination at Nursing Homes Cuts COVID-19 Infections
Increase in vaccination rate linked to fewer COVID-19 cases and deaths among residents, cases among staff
Flu Vaccine 36 Percent Effective Against A(H3N2) in 2021/2022
All sequenced A(H3N2) viruses belonged to genetic group 3C.2a1b subclade 2a.2, which was antigenically different from 2021-2022 vaccine component
No Increase in Adverse Events Seen With COVID-19 Vaccination After MIS-C
Minor adverse events seen in 48.6 percent of patients, most often arm soreness and/or fatigue
